4.8 Article

Harnessing CD4+ T cell responses in HIV vaccine development

Journal

NATURE MEDICINE
Volume 19, Issue 2, Pages 143-149

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm.3054

Keywords

-

Funding

  1. Division of AIDS of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (NIH)
  2. Ragon Institute
  3. Center for HIV/AIDS Immunology and Immunogen Discovery
  4. NIH [U19AI090970, P01AI096187]
  5. Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]
  6. US Department of Defense
  7. [R01AI094602-01]
  8. [R01 AI091450-01]

Ask authors/readers for more resources

CD4(+) T cells can perform a panoply of tasks to shape an effective response against a pathogen. Limited attention has been paid to the potential importance of functional CD4(+) T cell responses in the context of the development of next-generation vaccines, including HIV vaccines. Many CD4(+) T cell functions are newly appreciated and only partially understood. A workshop was held as a forum to bring together a small group of experts to exchange ideas on the role of CD4(+) T cells in developing durable functional antibody responses, via follicular helper T cells, as well as on the roles of CD4(+) T cells in other aspects of protective immunity. Here we discuss whether CD4(+) T cell responses may represent a beneficial component of an efficacious HIV vaccine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available